Anti-PD1 'SHR-1210' aberrantly targets pro-angiogenic receptors and this polyspecificity can be ablated by paratope refinement.

Saved in:
Bibliographic Details
Title: Anti-PD1 'SHR-1210' aberrantly targets pro-angiogenic receptors and this polyspecificity can be ablated by paratope refinement.
Authors: Finlay WJJ; a UltraHuman Limited, Codebase , Edinburgh , UK., Coleman JE; a UltraHuman Limited, Codebase , Edinburgh , UK., Edwards JS; a UltraHuman Limited, Codebase , Edinburgh , UK., Johnson KS; a UltraHuman Limited, Codebase , Edinburgh , UK.
Source: MAbs [MAbs] 2019 Jan; Vol. 11 (1), pp. 26-44. Date of Electronic Publication: 2018 Dec 12.
Publication Type: Journal Article
Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101479829 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1942-0870 (Electronic) Linking ISSN: 19420862 NLM ISO Abbreviation: MAbs Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1942-0870
DOI:10.1080/19420862.2018.1550321